Different tumor-derived p53 mutants exhibit distinct biological activities
- PMID: 2218501
- DOI: 10.1126/science.2218501
Different tumor-derived p53 mutants exhibit distinct biological activities
Abstract
In its wild-type form, the protein p53 can interfere with neoplastic processes. Tumor-derived cells often express mutant p53. Full-length mutant forms of p53 isolated so far from transformed mouse cells exhibit three common properties in vitro: loss of transformation-suppressing activity, gain of pronounced transforming potential, and ability to bind the heat shock protein cognate hsc70. A tumor-derived mouse p53 variant is now described, whose site of mutation corresponds to a hot spot for p53 in human tumors. While absolutely nonsuppressing, it is only weakly transforming and exhibits no detectable hsc70 binding. The data suggest that the ability of a p53 mutant to bind endogenous p53 is not the sole determinant of its oncogenic potential. The data also support the existence of gain-of-function p53 mutants.
Similar articles
-
Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.Cell Growth Differ. 1990 Dec;1(12):571-80. Cell Growth Differ. 1990. PMID: 2288874
-
The p53 tumor suppressor gene and gene product.Princess Takamatsu Symp. 1989;20:221-30. Princess Takamatsu Symp. 1989. PMID: 2488233 Review.
-
Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.Mol Cell Biol. 1988 Feb;8(2):531-9. doi: 10.1128/mcb.8.2.531-539.1988. Mol Cell Biol. 1988. PMID: 2832726 Free PMC article.
-
Nuclear localization is essential for the activity of p53 protein.Oncogene. 1991 Nov;6(11):2055-65. Oncogene. 1991. PMID: 1719467
-
The oncogenic roles of p53 mutants in mouse models.Curr Opin Genet Dev. 2007 Feb;17(1):66-70. doi: 10.1016/j.gde.2006.12.003. Epub 2007 Jan 8. Curr Opin Genet Dev. 2007. PMID: 17208429 Review.
Cited by
-
p53 is frequently mutated in Burkitt's lymphoma cell lines.EMBO J. 1991 Oct;10(10):2879-87. doi: 10.1002/j.1460-2075.1991.tb07837.x. EMBO J. 1991. PMID: 1915267 Free PMC article.
-
Murine models of neoplasia: functional analysis of the tumour suppressor genes Rb-1 and p53.Cancer Metastasis Rev. 1995 Jun;14(2):125-48. doi: 10.1007/BF00665796. Cancer Metastasis Rev. 1995. PMID: 7554030 Review.
-
Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma.Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2827-31. doi: 10.1073/pnas.90.7.2827. Proc Natl Acad Sci U S A. 1993. PMID: 8464896 Free PMC article.
-
p53 mutations and overexpression in locally advanced breast cancers.Br J Cancer. 1994 Jun;69(6):1145-50. doi: 10.1038/bjc.1994.225. Br J Cancer. 1994. PMID: 8198984 Free PMC article.
-
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response.Nat Commun. 2024 Jan 2;15(1):180. doi: 10.1038/s41467-023-44239-2. Nat Commun. 2024. PMID: 38167338 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous